{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:16:57Z","timestamp":1775650617813,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-05920-4","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:45:51Z","timestamp":1772567151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of neoadjuvant chemotherapy with lenvatinib plus pembrolizumab in advanced endometrial cancer: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-2950","authenticated-orcid":false,"given":"Katsuyuki","family":"Konnai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuguto","family":"Notomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Yokozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruya","family":"Saji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"5920_CR1","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2025.36.e119","author":"Oncology JSoG","year":"2023","unstructured":"Oncology JSoG. Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasms. J Gynecol Oncol. 2023. https:\/\/doi.org\/10.3802\/jgo.2025.36.e119.","journal-title":"J Gynecol Oncol"},{"key":"5920_CR2","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1200\/JCO.22.02152","volume":"41","author":"V Makker","year":"2023","unstructured":"Makker V, Colombo N, Casado Herr\u00e1ez A, et al. Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: updated efficacy and safety from the randomized phase III study 309\/KEYNOTE-775. J Clin Oncol. 2023;41:2904\u201310.","journal-title":"J Clin Oncol"},{"key":"5920_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/iju5.12584","volume":"6","author":"H Sato","year":"2023","unstructured":"Sato H, Sazuka T, Fujimoto A, et al. A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy. IJU Case Rep. 2023;6:185\u20139.","journal-title":"IJU Case Rep"},{"key":"5920_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1159\/000534000","volume":"16","author":"J Ell","year":"2023","unstructured":"Ell J, Balz P, Manava P, H\u00fcttenbrink C. Downstaging and pathological complete response of locally recurrent sarcomatoid renal cell carcinoma under pembrolizumab and lenvatinib: a case report and review of literature. Case Rep Oncol. 2023;16:1245\u201352.","journal-title":"Case Rep Oncol"},{"key":"5920_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/iju5.12668","volume":"7","author":"T Hara","year":"2024","unstructured":"Hara T, Furukawa J, Tsutiya T, et al. Cine magnetic resonance imaging predicts thrombus adhesion in metastatic renal cell carcinoma with an inferior vena cava tumor thrombus: a case of pathological complete response with pembrolizumab plus lenvatinib. IJU Case Rep. 2024;7:60\u20133.","journal-title":"IJU Case Rep"},{"key":"5920_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3348\/jksr.2022.0067","volume":"84","author":"J Choi","year":"2023","unstructured":"Choi J, Shin JH, Chu HH. Transcatheter arterial embolization for palliation of uterine body cancer bleeding. J Korean Soc Radiol. 2023;84:606\u201314.","journal-title":"J Korean Soc Radiol"},{"key":"5920_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.609235","volume":"10","author":"MD Tucker","year":"2020","unstructured":"Tucker MD, Beckermann KE, Gordetsky JB, et al. Complete pathologic responses with immunotherapy in metastatic renal cell carcinoma: case reports. Front Oncol. 2020;10: 609235.","journal-title":"Front Oncol"},{"key":"5920_CR8","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/annonc\/mdy218","volume":"29","author":"TR Cottrell","year":"2018","unstructured":"Cottrell TR, Thompson ED, Forde PM, et al. Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC). Ann Oncol. 2018;29:1853\u201360.","journal-title":"Ann Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-05920-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:35:20Z","timestamp":1775648120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-05920-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5920"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-05920-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Institutional Review Board of Kanagawa Cancer Center (IRB approval number EKI119). We have obtained written informed consent from the patient regarding publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent was made available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests regarding the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}